Proposal for a new local recurrence score in patients with recurrent malignant pleural mesothelioma

September 29, 2022 | Comments Off on Proposal for a new local recurrence score in patients with recurrent malignant pleural mesothelioma

Journal of Thoracic Disease 2022 August [Link] Olivia Lauk, Thomas Neuer, Bianca Battilana, Ilhan Inci, Katarzyna Furrer, Walter Weder, Masaki Hashimoto, Isabelle Opitz Abstract Background: Malignant pleural mesothelioma (MPM) is…

Brief Report: Multimodality Therapy in Patients with Primary Pericardial Mesothelioma

September 28, 2022 | Comments Off on Brief Report: Multimodality Therapy in Patients with Primary Pericardial Mesothelioma

Journal of Thoracic Oncology 2022 September 5 [Link] Michael Offin, Dilanka De Silva, Jennifer L Sauter, Jacklynn V Egger, Ellen Yorke, Prasad S Adusumilli, Andreas Rimner, Valerie W Rusch, Marjorie…

Survival Effect of Complete Multimodal Therapy in Malignant Pleural Mesothelioma

September 27, 2022 | Comments Off on Survival Effect of Complete Multimodal Therapy in Malignant Pleural Mesothelioma

Journal of Chest Surgery 2022 September 7 [Link] Muhammet Sayan, Aynur Bas, Merve Satir Turk, Dilvin Ozkan, Ali Celik, İsmail Cuneyt Kurul, Abdullah Irfan Tastepe Abstract Background: Malignant pleural mesothelioma…

Meta-analysis of survival after extrapleural pneumonectomy (EPP) versus pleurectomy/decortication (P/D) for malignant pleural mesothelioma in the context of macroscopic complete resection (MCR)

September 26, 2022 | Comments Off on Meta-analysis of survival after extrapleural pneumonectomy (EPP) versus pleurectomy/decortication (P/D) for malignant pleural mesothelioma in the context of macroscopic complete resection (MCR)

Updates in Surgery 2022 September 3 [Link] Dimitrios E Magouliotis, Prokopis-Andreas Zotos, Arian Arjomandi Rad, Despoina Koukousaki, Vasiliki Vasilaki, Ioustini Portesi, Kyriakos Spiliopoulos, Thanos Athanasiou Abstract Objective: We reviewed the…

A trial of intra-pleural bacterial immunotherapy in malignant pleural mesothelioma (TILT) – a randomised feasibility study using the trial within a cohort (TwiC) methodology

September 23, 2022 | Comments Off on A trial of intra-pleural bacterial immunotherapy in malignant pleural mesothelioma (TILT) – a randomised feasibility study using the trial within a cohort (TwiC) methodology

Pilot & Feasibility Studies 2022 September 3 [Link] Anna C Bibby, Natalie Zahan-Evans, Emma Keenan, Charles Comins, John E Harvey, Helen Day, Najib M Rahman, Janet E Fallon, Rachael Gooberman-Hill,…

Feasibility and safety of extended pleurectomy/decortication for malignant pleural mesothelioma. A single group experience

September 22, 2022 | Comments Off on Feasibility and safety of extended pleurectomy/decortication for malignant pleural mesothelioma. A single group experience

Thoracic Cancer 2022 September 2 [Link] Francesco Falanga, Pietro Rinaldi, Cristiano Primiceri, Chandra Bortolotto, Olga Oneta, Francesco Agustoni, Patrizia Morbini, Laura Saracino, Dimitrios Eleftheriou, Federico Sottotetti, Giulia Maria Stella Abstract…

IL-7 is expressed in malignant mesothelioma and has a prognostic value

September 21, 2022 | Comments Off on IL-7 is expressed in malignant mesothelioma and has a prognostic value

Molecular Oncology 2022 August 28 [Link] Hoa-Le Mai, Sophie Deshayes, Thi-Van-Ha Nguyen, Virginie Dehame, Anne-Laure Chéné, Sophie Brouard, Christophe Blanquart Abstract Malignant pleural mesothelioma (MPM) is an aggressive cancer mainly…

Malignant Peritoneal Mesothelioma Presenting with High Protein, High Serum-Ascites Albumin Gradient

September 20, 2022 | Comments Off on Malignant Peritoneal Mesothelioma Presenting with High Protein, High Serum-Ascites Albumin Gradient

Case Reports Cureus 2022 July 26 [Link] Zachary P Kerosky, Charleston R Powell, Phillip C Lindholm Abstract Mesothelioma is a difficult-to-detect neoplasm that rarely develops in the peritoneum. In patients…

Prognostic risk assessment model for alternative splicing events and splicing factors in malignant pleural mesothelioma

September 19, 2022 | Comments Off on Prognostic risk assessment model for alternative splicing events and splicing factors in malignant pleural mesothelioma

Cancer Medicine 2022 August 28 [Link] Yue Jiang, Chengda Zhang, Yang Chen, Shiyu Zhao, Yipeng He, Jun He Abstract Background: Malignant pleural mesothelioma (MPM) is a rare and highly malignant…

PSO-Based Evolutionary Approach to Optimize Head and Neck Biomedical Image to Detect Mesothelioma Cancer

September 16, 2022 | Comments Off on PSO-Based Evolutionary Approach to Optimize Head and Neck Biomedical Image to Detect Mesothelioma Cancer

Biomed Research International 2022 August 5 [Link] Sheeba Praveen, Neha Tyagi, Bhagwant Singh, Girija Rani Karetla, Meenakshi Anurag Thalor, Kapil Joshi, Melkamu Tsegaye Abstract Mesothelioma is a form of cancer…

Categories